Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
SEC Filings
Filing date | Form | Description | Filing Group | View |
---|---|---|---|---|
8-K |
Report of unscheduled material events or corporate event |
Current Reports
|
||
10-Q |
Quarterly report which provides a continuing view of a company's financial position |
Quarterly Filings
|
||
8-K |
Report of unscheduled material events or corporate event |
Current Reports
|
||
424B4 |
Form of prospectus disclosing information facts events covered in both forms 424B1 424B3 |
Registration Statements
|
||
EFFECT |
EFFECT |
Other
|
||
S-1 |
Registration statement for face-amount certificate companies |
Registration Statements
|
||
CORRESP |
CORRESP |
Other
|
||
CORRESP |
CORRESP |
Other
|
||
DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Proxy Filings
|
||
DEFA14A |
Additional proxy soliciting materials - definitive |
Proxy Filings
|
Displaying 401 - 410 of 500 results
Data provided by Kaleidoscope.